These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3589695)

  • 1. Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia.
    Raza A; Maheshwari Y; Mandava N; Yasin Z; Perveen S; Mayers G; Browman G; Goldberg J; Gottlieb A; Grunwald H
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):217-25. PubMed ID: 3589695
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the cytotoxicity of cytosine arabinoside.
    Haanen C; Muus P; Raymakers R; Drenthe-Schonk A; Salden M; Wessels J
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):120-9. PubMed ID: 3892698
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular and clinical pharmacology of low-dose ara-C.
    Kufe DW; Griffin JD; Spriggs DR
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):200-7. PubMed ID: 3925558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo assessment of sensitivity to ara-C in myeloid leukemias.
    Raza A; Ucar K; Preisler HD; Mayers G
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):9-19. PubMed ID: 3892706
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of ara-C metabolism in acute leukemia.
    Ross DD; Thompson BW; Joneckis CC; Akman SA; Schiffer CA
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):182-91. PubMed ID: 3589693
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.
    Raza A; Gezer S; Anderson J; Lykins J; Bennett J; Browman G; Goldberg J; Larson R; Vogler R; Preisler HD
    Exp Hematol; 1992 Nov; 20(10):1194-200. PubMed ID: 1426099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell cycle effect of cytosine arabinoside, vincristine, and massive leukapheresis on human leukemic blasts and its application to a quadruple combination chemotherapy of acute leukemia (author's transl)].
    Yoshikawa H; Takeyama H; Nagata K; Ueda R; Ishiguro J
    Rinsho Ketsueki; 1975 Jan; 16(1):8-18. PubMed ID: 1172041
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo perturbation of human marrow cell cycle progression by ifosfamide.
    Rentschler RE; Barlogie B; Johnston DA; Bodey GP
    Cancer Res; 1978 Aug; 38(8):2209-15. PubMed ID: 667817
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro assessment of drug sensitivity in acute nonlymphocytic leukemia.
    Preisler HD; Raza A
    Recent Results Cancer Res; 1984; 94():102-15. PubMed ID: 6593774
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the rate of DNA synthesis in myeloblasts from peripheral blood and bone marrows of patients with acute nonlymphocytic leukemia.
    Raza A; Yasin Z; Grande C
    Exp Cell Res; 1988 May; 176(1):13-9. PubMed ID: 3371420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical criteria of the sensitivity of patients with leukosis to 6-mercaptopurine and cytosar].
    Gerasimova GK; Sidorova TA; Volkova MA; Maiakova SA; Golenko OD
    Vestn Akad Med Nauk SSSR; 1984; (5):78-85. PubMed ID: 6540013
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular pharmacodynamics of anticancer drugs.
    Plunkett W; Gandhi V
    Semin Oncol; 1993 Feb; 20(1):50-63. PubMed ID: 8475410
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of DNA synthesis by cytosine arabinoside: relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease.
    Preisler HD; Epstein J; Raza A; Azarnia N; Browman G; Booker L; Goldberg J; Gottlieb A; Brennan J; Grunwald H
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1061-8. PubMed ID: 6540689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells.
    Chou TC; Arlin Z; Clarkson BD; Phillips FS
    Cancer Res; 1977 Oct; 37(10):3561-70. PubMed ID: 332337
    [No Abstract]   [Full Text] [Related]  

  • 15. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.
    Raza A; Ucar K; Preisler HD
    Cytometry; 1985 Nov; 6(6):633-40. PubMed ID: 3905302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell kinetics and practical consequences for therapy of acute leukemia.
    Bleich HL; Boro ES
    N Engl J Med; 1975 Aug; 293(8):389-93. PubMed ID: 1057045
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of early relapsing patients with adult acute nonlymphocytic leukemia by bone marrow biopsy after initial induction chemotherapy.
    Cassileth PA; Gerson SL; Bonner H; Neiman RS; Lusk EJ; Hurwitz S
    J Clin Oncol; 1984 Feb; 2(2):107-11. PubMed ID: 6699661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells.
    Akman SA; Ross DD; Joneckis CC; Fox BM; Bachur NR
    Cancer Treat Rep; 1985; 69(7-8):851-7. PubMed ID: 4016794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.
    Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Walker I; Browman M; Grunwald H; D'Arrigo P; Doeblin T
    J Clin Oncol; 1987 Jan; 5(1):75-82. PubMed ID: 3806162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
    Creasey WA; DeConti RC; Kaplan SR
    Cancer Res; 1968 Jun; 28(6):1074-81. PubMed ID: 5241767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.